Univ. of Maryland / Greenebaum Comp. Cancer Ctr. — Baltimore, Maryland

Univ. of Maryland / Greenebaum Comp. Cancer Ctr. is a clinical research site located in Baltimore, Maryland, United States 21201.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Univ. of Maryland / Greenebaum Comp. Cancer Ctr. has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion.

Sponsors: Bayer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Univ. of Maryland / Greenebaum Comp. Cancer Ctr.?

Univ. of Maryland / Greenebaum Comp. Cancer Ctr. has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Univ. of Maryland / Greenebaum Comp. Cancer Ctr. conducted?

Univ. of Maryland / Greenebaum Comp. Cancer Ctr. has 1 clinical trials on record, with 1 currently active. Their work covers Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion.

Is Univ. of Maryland / Greenebaum Comp. Cancer Ctr. accredited by Crixeo Health?

Univ. of Maryland / Greenebaum Comp. Cancer Ctr. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Univ. of Maryland / Greenebaum Comp. Cancer Ctr.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.